Webinars by Biopharma Group

Each lyophilization training course or webinar is tailored to be up to date with contemporary material and industry relevant developments.

With over 6000 individuals trained and more than 400+ courses conducted in over 45 cities around the world, Biopharma Group has built a sound reputation as a trusted resource for lyophilization training to the pharma, diagnostics and biotech industries.

At Biopharma Group we believe that well trained lab teams, production and engineering departments are empowered to use lyophilization technology and processes to produce successful product results and improve the overall processes of your facility.

Our webinars, across a variety of lyo related topics, run regularly and continue to grow in popularity, so keep an eye on this page to see what is added next.

If you'd can't make one of our webinars, please get in touch to ask to be contacted if it is run again. Additionally, if interested in our scheduled or customized training courses, contact us to discuss your requirements with one of the team .

Biopharma Group Webinars

23rd September 2025, 09:00 (PST)

Webinar (Free)

When Lyocakes Go Bad - How to Identify & Fix It

Register Your Interest for the Next Webinar

Webinar (Free)

Freeze-Drying ADCs: From Basics to Breakthrough

Register Your Interest for the Next Webinar

Webinar (Free)

Is it Time to Switch to Lyobeads?

Scheduled Courses:

Modular E-learning Videos:

Bespoke/Customized On-Site & Online Courses:

Our Scientific Team:

At Biopharma Group, our scientists and consultants approach each new project with a depth of experience and knowledge capable of reaching any goal that you expect from a CDMO partner. Each of our projects is carefully managed with access to proprietary and advanced equipment to ensure that both R&D and manufacturing projects run smoothly.

Our specialist tutors are active in the field of lyophilization and are always keen to offer the most relevant, accurate information based on practice and experience. With substantial knowledge of the challenges of operating an efficient freeze-drying process, our experts are able to discuss and explain the issues that you may encounter along the way.

Customer Testimonials

  • “We are very grateful for our collaboration with Biopharma Group and for their valuable help in the development of our lyophilization process. Their expertise and commitment played an important role in achieving results that exceeded our expectations. As a testament to our joint effort, we launched our first lyo-compatible qPCR mix - SolisFAST® Lyo- Ready qPCR Kit with UNG. We appreciate their genuine dedication to our project and look forward to continued success together.”
    Product Specialist
    Solis Biodyne
  • “Through my experience of working with Biopharma Group on various lyo projects, I can happily say that I have always been super impressed with the results that we have received! We will definitely continue to make Biopharma Group our first choice when needing to outsource freeze drying support.”
    Director of Business Development
    Nanopharm
  • We have had the opportunity to work with Biopharma Group on several projects to optimize and improve freeze-drying processes. Biopharma Group has real expertise that is put to the benefit of its customers. The responsiveness of their teams and the tools used have always been highly appreciated.
    Deputy Head of Industrial Development
    Galien
  • We worked with Biopharma group very intensively around Lyo project development. I was very much impressed and enjoyed working with the team that provided detailed, and regular updates on project progress, challenges, and solutions.
    Chief Development Officer
    Code Pharma
  • The information provided by the Biopharma Group team helped me to improve the quality of our product, and in particular helped me to develop more effective and efficient processes for transferring our products from research to the production stage.
    Director of Tech Transfer Department
    Evik
  • Theragenix has benefited from Biopharma Group services to develop a formulation suitable for lyophilisation. The project involved a freeze drying cycle and a series of analyses for stability studies. Both technical and commercial support has been very appreciated
    Chief Executive Officer
    Theragenix
  • “Thank you for being so professional, helpful, innovative and friendly. We were extremely impressed with the quality of your service.”
    Director
    Oxford MediStress
  • “We elected to work with Biopharma because of their full service and years of experience. They helped us with analysis and troubleshooting of our product and we were impressed by the quality and responsiveness of their scientists. We would definitely use them again.”
    Scientist
    Millipore Sigma
  • “Biopharma developed a successful cycle for us, their quality and technical support was excellent.”
    CMC Lead
    Themis
  • “Biopharma helped develop our cycle, we are extremely satisfied with their quality and service and would thoroughly recommend them to others.”
    Lab Manager
    Primer Design
  • “Biopharma Group quickly understood our radiopharmaceutical challenges and provided effective solutions. Their team is highly responsive, knowledgeable, and a pleasure to work with.”
    Chief Technical Officer
    Isotopia
  • “We chose Biopharma because of their reputation and expertise in the field of lyophilisation and we were impressed with their overall excellent level of service. We would recommend them.”
    Extraction Scientist
    GlaxoSmithKline
  • "Biopharma Group always offered fast and reliable results in our Freeze Dry Microscopy studies. Big thanks for a great team!"
    Product Development Scientist
    Teva
  • “We worked with Biopharma Group for the development and deployment of an antibody freeze drying process to support preclinical studies. They rapidly provided technical insights to guide the design of the process development study and helped troubleshoot unexpected results. The team’s experience was critical to the success of this project, and we benefitted from an open and collaborative approach throughout.”
    Chief Business Officer
    Evitria